Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences
(RTTNews) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical company focused exclusively on Women's Health.
Lupin's U.S. Commercial Women's Health Specialty Business is primarily focused on commercializing SOLOSEC (secnidazole) 2g oral granules.
This FDA-approved single-dose antimicrobial agent provides a complete course of therapy for the treatment of bacterial vaginosis (BV) and trichomoniasis, two common sexual health infections.
read more
Evofem Biosciences Names Albert Altro As Interim CFO
Evofem Biosciences, Inc. (EVFM) announced Thursday the appointment of Albert Altro as Interim Chief Financial Officer of the Company. He replaces Jay File, who is leaving the Company to explore other opportunities.
RTTNews
|
719 days ago
Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved In Nigeria
Evofem Biosciences, Inc. (EVFM) announced Thursday that its hormone-free contraceptive vaginal gel Phexxi has been approved by the Nigerian Regulatory Agency NAFDAC (National Agency for Food and Drug Administration and Control). This is the first regulatory approval outside the U.S.
RTTNews
|
873 days ago
Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi
Evofem Biosciences, Inc. (EVFM) announced Tuesday it has reached an agreement with one of the nation's largest pharmacy benefit managers (PBMs) to ensure most women covered by this plan can fill their Phexxi prescriptions for pregnancy prevention, without restrictions such as prior authorization or step therapy. Phexxi is an on-demand method of birth control used to prevent pregnancy.
RTTNews
|
973 days ago
U.S. Consumer Confidence Tumbles Much More Than Expected In February
A report released by the Conference Board on Tuesday showed a significant deterioration by U.S. consumer confidence in the month of February. The Conference Board said its consumer confidence index tumbled to 98.3 in February from an upwardly revised 105.3 in January. Economists had expected the consumer confidence index to dip to 103.0 from the 104.1 originally reported for the previous month.
RTTNews
|
6h 2min ago
Bay Street Likely To Open Higher, But Tariff Jitters, Weak Commodities May Weigh
Canadian shares may open higher Tuesday morning on bank earnings, but weak commodities and tariff jitters could limit market's upside.
U.S. President Donald Trump stated on Monday tariffs on Canadian and Mexican imports remain "on time and on schedule," raising fears of a prolonged trade war.
RTTNews
|
7h 49min ago
Home Depot Q4 Beats Market; Sees Weak Earnings, Higher Sales In FY25; Stock Drops
Home Depot Inc., while reporting higher fourth-quarter results above market estimates, on Tuesday issed fiscal 2025 guidance, expecting weak earnings, but higher sales and comparable sales. Further, the home improvement retailer announced higher quarterly dividend. In pre-market activity on the NYSE, Home Depot shares were losing around 2.4 percent.
RTTNews
|
9h 38min ago
Yen Rises On BoJ Rate Hike Bets
The Japanese yen strengthened against other major currencies in the European session on Tuesday amid rising speculation that the Bank of Japan (BoJ) will hike interest rates further.
RTTNews
|
9h 39min ago
FTSE Advances; Smith & Nephew Climb Higher On Results
U.K. stocks are modestly higher Tuesday morning with investors digesting some earnings updates and other corporate news while continuing to follow the developments in Germany where a new government is set to take charge soon. Worries about fresh U.S. tariffs and uncertainty about the Trump administration's economic policies limit market's upside.
RTTNews
|
10h 45min ago
